for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China Grand Pha.and Healthcare Hld. Ltd.

0512.HK

Latest Trade

4.15HKD

Change

0.04(+0.97%)

Volume

1,036,000

Today's Range

4.07

 - 

4.15

52 Week Range

3.26

 - 

5.45

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

China Grand Pharmaceutical And Healthcare's Unit To Acquire 24.6% Stake In Wuhan Grand Hoyo

Nov 20 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::UNIT TO ACQUIRE 24.6% EQUITY INTEREST IN WUHAN GRAND HOYO CO LTD.UNIT TO ACQUIRE WUHAN GRAND HOYO FROM WUHAN UNIVERSITY ASSET INVESTMENT & MANAGEMENT FOR RMB73.7 MILLION.

China Grand Pharmaceutical and Healthcare Signs Agreement With Griffith University

Nov 18 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>: :SIGNS EXCLUSIVE LICENSING & DEVELOPMENT AGREEMENT WITH GRIFFITH UNIVERSITY FOR PARAINFLUENZA DRUG.

China Grand Pharmaceutical And Healthcare Obtains Medical Device Registration Certificate For Product

Oct 14 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE FOR A CORONARY INTERVENTION PRODUCT IN PRC MARKET.

China Grand Pharmaceutical And Healthcare Says Grand Decade To Buy Stake In Oncosec Medical

Oct 10 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::GRAND DECADE TO BUY 10 MILLION ONCOSEC SHARES, REPRESENTING APPROXIMATELY 44.2% OF SHARE CAPITAL OF ONCOSEC.DEAL FOR US$25 MILLION IN CASH.SIRTEX ALSO TO BUY 2 MLN ONCOSEC SHARES AT US$2.50 PER ONCOSEC SHARE.

China Grand Pharmaceutical And Healthcare HY Revenue Hk$3.59 Billion

Aug 13 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::HY REVENUE HK$3.59 BILLION VERSUS HK$3.24 BILLION.HY PROFIT FOR PERIOD ATTRIBUTABLE TO OWNERS OF COMPANY HK$547 MILLION VERSUS HK$315.4 MILLION.

China Grand Pharmaceutical And Healthcare Expects HY Consol Net Profit Attributable To Rise Not Less Than 50%

July 10 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::EXPECTED THAT CONSOLIDATED NET PROFIT ATTRIBUTABLE FOR HY RECORDED INCREASE OF NOT LESS THAN 50%.EXPECTED RESULT DUE TO GROWTH IN TURNOVER OF CORE PRODUCTS & HIGH GROSS PROFIT MARGIN PRODUCTS.

China Grand Pharmaceutical & Healthcare Says Vigabatrin Tablet To Be Included In Priority Review & Approval List

March 27 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::VIGABATRIN TABLET IS PROPOSED TO BE INCLUDED IN PRIORITY REVIEW AND APPROVAL LIST.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE - DRUG INCLUDED DUE TO ITS COMPLIANCE WITH FORMER CHINA FOOD AND DRUG ADMINISTRATION.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE -DRUG COMPLIES WITH FORMER CFDA'S OPINIONS ON IMPLEMENTATION OF PRIORITY REVIEW,APPROVAL OF DRUG INNOVATION.

China Grand Pharmaceutical And Healthcare Holdings Posts FY Profit Attributable HK$712.67 MLN

March 26 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::FY REVENUE HK$5,958.36 MILLION VERSUS HK$4,770.85 MILLION.PROFIT FOR YEAR ATTRIBUTABLE HK$712.67 MILLION VERSUS HK$460.81 MILLION.BOARD PROPOSED A FINAL DIVIDEND OF HK$0.086 PER SHARE..

China Grand Pharmaceutical And Healthcare Says CFIUS Clears Sirtex Acquisition

March 12 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::COMMITTEE ON FOREIGN INVESTMENT IN UNITED STATES CLEARED ACQUISITION OF SIRTEX MEDICAL.

China Grand Pharmaceutical And Healthcare Holdings Enters Exclusive License Agreement

Feb 8 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::ENTERED EXCLUSIVE LICENSE AGREEMENT WITH GLENMARK SPECIALTY S.A.GLENMARK WILL BE RESPONSIBLE FOR MANUFACTURE AND SUPPLY OF LICENSED PRODUCT.CO WILL BE RESPONSIBLE FOR CLINICAL TRIAL AND REGISTRATION OF LICENSED PRODUCT IN CHINA.UNDER DEAL GLENMARK TO DISTRIBUTE RYALTRIS, A NASAL SPRAY OF ANTI-HISTAMINE & STEROID IN CHINA.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up